| 11/13/2018 | BKCAHY | Valeant lifts term loan to $1.5 billion, cancels potential bond deal
|
| 11/8/2018 | BKCADDHY | Fitch rates Valeant loan BB-
|
| 11/7/2018 | CAHY | Valeant mulls new junk bond issue to help fund tender for 7½% notes
|
| 5/17/2018 | BKCADDHY | Fitch rates Valeant facility BB-, notes B-
|
| 5/15/2018 | BKCAHY | Moody’s rates Valeant loans Ba3
|
| 3/12/2018 | BKCAHY | S&P gives B- to Valeant notes
|
| 9/21/2012 | CA | Moody's: Valeant unaffected by bond upsizing
|
| 9/20/2012 | CAHY | New Issue: Valeant Pharmaceuticals prices restructured $2.25 billion two-part deal
|
| 5/3/2011 | BKCACVHY | Moody's confirms Valeant
|
| 3/9/2011 | BKCACVHY | S&P rates Valeant notes BB-
|
| 3/4/2011 | CA | Market Commentary: Ontario sells C$600 million add-on; Skylink markets notes; municipal deals to pick up
|
| 3/3/2011 | CA | Market Commentary: Valeant Pharmaceuticals wraps deal; Skylink starts roadshow; Vermilion 6.5% notes stronger
|
| 3/3/2011 | CAHY | New Issue: Valeant Pharmaceuticals sells $1.5 billion senior notes in two parts
|
| 3/2/2011 | BKCACVHY | Moody's cuts Valeant to stable, rates notes Ba3
|
| 3/2/2011 | BKCACVHY | S&P rates Valeant notes BB-
|
| 3/1/2011 | CAHY | Valeant Pharmaceuticals launches $1.5 billion notes offering
|
| 2/7/2011 | BKCACVHY | S&P assigns Valeant loan BB+, notes BB-
|
| 2/3/2011 | BKCACVHY | Moody's rates Valeant notes B1
|
| 2/3/2011 | BKCACVHY | S&P rates Valeant notes BB-
|
| 2/3/2011 | CA | Market Commentary: Royal Bank of Canada, Vermilion, Valeant fill appetites; interest keen in oil, gas bonds
|
| 2/3/2011 | CAHY | New Issue: Valeant Pharmaceuticals prices $650 million 10.5-year notes at par to yield 63/4%
|
| 11/23/2010 | CA | Market Commentary: Glacier Credit Card, AltaGas, Canadian Western Bank flood market; Paramount to start roadshow
|
| 11/22/2010 | CA | Market Commentary: Potash sells $1 billion two-part U.S. deal; BAM Split brings preferreds; Valeant widens
|
| 11/19/2010 | CA | Market Commentary: Fortis week's third utility deal; Quebec sells C$500 million; Cara roadshow gains interest
|
| 11/18/2010 | CA | Market Commentary: Capital Desjardins, Newalta, Valeant Pharmaceuticals lift high-grade, junk bond markets
|
| 11/18/2010 | CAHY | New Issue: Valeant Pharmaceuticals sells upsized $1 billion 6 7/8% eight-year notes to yield 7%
|
